Myriad Genetics, Inc. Profile Avatar - Palmy Investing

Myriad Genetics, Inc.

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health …

Medical - Diagnostics & Research
US, Salt Lake City [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Myriad Genetics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of MYGN's Analysis
CIK: 899923 CUSIP: 62855J104 ISIN: US62855J1043 LEI: - UEI: -
Secondary Listings
MYGN has no secondary listings inside our databases.